On Monday, Organogenesis Holdings Inc (NASDAQ: ORGO) was 11.07% up from the session before settling in for the closing price of $4.88. A 52-week range for ORGO has been $2.16 – $6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 14.32%. When this article was written, the company’s average yearly earnings per share was at 626.00%. With a float of $64.38 million, this company’s outstanding shares have now reached $125.73 million.
Considering the fact that the conglomerate employs 869 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 74.32%, operating margin of -0.27%, and the pretax margin is -0.58%.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Organogenesis Holdings Inc stocks. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 49.46%. The most recent insider transaction that took place on Mar 04 ’25, was worth 127,000. Before that another transaction happened on Mar 04 ’25, when Company’s Director sold 25,000 for $5.10, making the entire transaction worth $127,535. This insider now owns 166,879 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 626.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
You can see what Organogenesis Holdings Inc (ORGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.43. Likewise, its price to free cash flow for the trailing twelve months is 164.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.19 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Compared to the last year’s volume of 1.88 million, its volume of 1.43 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.00%. Additionally, its Average True Range was 0.41.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 67.42%, which indicates a significant increase from 48.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.85% in the past 14 days, which was lower than the 137.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.07, while its 200-day Moving Average is $3.29. Nevertheless, the first resistance level for the watch stands at $5.67 in the near term. At $5.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.31. If the price goes on to break the first support level at $5.02, it is likely to go to the next support level at $4.62. Now, if the price goes above the second support level, the third support stands at $4.37.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are 126,828K outstanding shares of the company, which has a market capitalization of 687.41 million. As of now, sales total 482,040 K while income totals 860 K. Its latest quarter income was 126,660 K while its last quarter net income were 7,670 K.
